About DRX


DesigneRx Pharmaceuticals, Inc. (DRX) a subsidiary of Polaris Group (www.polarispharma.com), is a therapeutic protein drug manufacturer located in Vacaville, California.  DRX has a cGMP facility to produce novel protein therapeutics to support clinical trials at various stages in the USA, Europe, and the Asian-Pacific region.  PEGylated Arginine Deiminase (ADI-PEG 20), the lead project of the company is now in clinical trials for patients with hepatocellular carcinoma, non-small cell lung cancer, melanoma, mesothelioma, pancreatic cancer, prostate cancer, leukemia, lymphoma, and breast cancer.  DRX manufactures all drugs for global clinical studies conducted by Polaris Group.